AUA
  • Program
  • Register
  • Meeting Coverage
  • Guidelines
  • Industry Highlights
  • Science & Technology Hall
Topics
  • Meeting Coverage
  • Guidelines
  • Industry Highlights
  • Science & Technology Hall
Resources
  • Program
  • Register
Twitter X icon Facebook iconInstagram iconYouTube iconLinkedIn icon
May 17, 2026

U-POP and LUTD care refined in international consensus report

The 2026 conference developed 101 consensus statements to guide care.


Prolapse Panel 03

The global consensus conference on uterine pelvic organ prolapse (U-POP) and lower urinary tract dysfunction (LUTD) conducted 29 systematic review searches, screened over 51,143 abstracts and reviewed 3,869 full-texts to develop 101 consensus statements.

One subgroup of the committee was assigned to assess the need for urologic testing prior to surgical therapy for primary uterovaginal prolapse.

There were 0 studies assessing the use of preoperative cystoscopy. However, the AUA guidelines recommend it for individuals with moderate- or high-risk microhematuria, recurrent urinary tract infections or anatomical concerns such as strictures.

“This led us to the consensus statement that clinicians should not perform office cystoscopy in patients undergoing primary uterovaginal prolapse repair without hematuria or urinary conditions mandating investigation,” said Emily Snethkamp, NP, University of Michigan Health Medical Center.

Five studies examined retention and found that patients with higher preoperative post-void residuals tended to have higher postoperative residuals. However, the urodynamics data were mixed. Based on this, the consensus reached is that clinicians may perform office post-void residual measurements in patients undergoing primary uterovaginal prolapse repair, especially those with lower urinary tract symptoms.

The group also examined stress urinary incontinence (SUI) and overactive bladder as postoperative outcomes.

“We concluded that clinicians should not perform urodynamics in patients undergoing primary uterovaginal prolapse repair to diagnose SUI since a reduced full bladder stress test provides immediate information and there are no urodynamic parameters that predict postoperative overactive bladder or voiding dysfunction. We also concluded that clinicians should perform an office full bladder stress test with the prolapse reduced in all patients undergoing primary uterovaginal prolapse care, even if they don't have urinary incontinence,” said Anne Pelletier Cameron, MD, a clinical professor at the University of Michigan Health Medical Center.

The consensus committee also looked at the risk factors for failure among women undergoing U-POP surgery.

“Previous studies have shown that age was a risk factor for failure, but when we looked at it in U-POP, we saw no association between age and failure. The next thing we looked at was body mass index, and we found an increased risk, though it was not very dramatic. The big risk factors we identified were advanced-stage prolapse, particularly stage four, which is at a much higher risk of recurrence,” said Catherine Matthews, MD, professor at Wake Forest University School of Medicine.

Additionally, based on Delphi consensus, clinicians should be aware that levator avulsion, enlarged genital hiatus and connective tissue disorders are risk factors for surgical recurrence.

When selecting a hysterectomy method, patients who are willing to accept a higher risk of mesh exposure and small-bowel injury tend to have a lower chance of failure if they opt for hysterectomy with sacrocolpopexy.

Interesting Stories
Unique formulation of YONSA® (abiraterone acetate) makes it different
Sponsored by Sun Pharma
Unique formulation of YONSA® (abiraterone acetate) makes it different
Book your AUA2026 housing now
Sponsored by AUA
Book your AUA2026 housing now
AUA means business: AUA Annual Business Meeting is May 18
Sponsored by AUA
AUA means business: AUA Annual Business Meeting is May 18
Find your next big break at AUA2026
Sponsored by AUA
Find your next big break at AUA2026
More Content
Anthony Herndon, MD
Meeting Coverage
Protecting scientific integrity in the era of AI
May 17, 2026
Crossfire 01
Meeting Coverage
Balancing risks and benefits of hydrodistension for IC/BPS
May 17, 2026
Tyson With Crowd
Meeting Coverage
New intravesical therapies show promise in NMIBC trials
May 17, 2026
From left: Kymora Scotland, MD, PhD; Taylor Brewer, MSM, PA; and Greg Tasian, MD, MSc, MSCE.
Meeting Coverage
New stone guidelines sharpen focus on patient-centered care
May 16, 2026
Jaspreet S. Sandhu, MD
Meeting Coverage
Updated BPH guidelines focus on patients, not procedures
May 16, 2026
Jennifer Robles, MD, MPH
Meeting Coverage
Antibiotic use clarified in stone removal guidelines
May 16, 2026
Ben H. Chew, MD, MSc
Meeting Coverage
Break Wave challenges standard lithotripsy approach
May 16, 2026
Advocacy 02
Meeting Coverage
Advocacy rewrites the label for HRT
May 16, 2026
Sara M. Lenherr, MD, MS, URPS
Meeting Coverage
Reinventing one of urology’s oldest tools
May 16, 2026
H. Gilbert Welch, MD, MPH
Meeting Coverage
The hidden cost of looking harder for cancer
May 15, 2026
Neal Shore, MD
Meeting Coverage
Durvalumab + BCG continues to deliver in high-risk NMIBC
May 15, 2026
Jean F.P. Lestingi, MD, PhD
Meeting Coverage
Updated trial refines role of extended lymph node dissection
May 15, 2026
AUA
Twitter X icon Facebook iconInstagram iconYouTube iconLinkedIn icon
© 2026 Ascend Media. All rights reserved.